微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 47.75% | -5.64% | -3.58% | 11/52 | 36.36% | 百奥赛图 | 74.91% | 行业排名> |
| 2025-06-30 | 49.53% | -5.11% | 0.09% | 8/52 | 36.49% | 百奥赛图 | 74.39% | 行业排名> |
| 2025-03-31 | 49.48% | -10.12% | 5.59% | 6/52 | 34.34% | *ST生物 | 64.96% | 行业排名> |
| 2024-12-31 | 46.86% | 4.73% | -7.4% | 11/52 | 35.25% | 百奥赛图 | 77.67% | 行业排名> |
| 2024-09-30 | 50.61% | 11.87% | -3.04% | 6/52 | 35.76% | *ST生物 | 68.03% | 行业排名> |
| 2024-06-30 | 52.2% | 20.27% | -5.19% | 6/52 | 36.65% | 百奥赛图 | 74.42% | 行业排名> |
| 2024-03-31 | 55.05% | 16.08% | 23.03% | 5/52 | 35.74% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 44.74% | 4.75% | -1.09% | 15/52 | 38.77% | 百奥赛图 | 70.59% | 行业排名> |
| 2023-09-30 | 45.24% | -0.64% | 4.23% | 16/52 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 43.4% | -5.44% | -8.49% | 20/52 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 47.42% | 2.52% | 11.02% | 12/52 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 42.72% | -4.51% | -6.17% | 23/52 | 40.75% | 百奥赛图 | 73.38% | 行业排名> |
| 2022-09-30 | 45.53% | -4% | -0.8% | 15/52 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 45.89% | -7.32% | -0.79% | 18/52 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 46.26% | -5.23% | 3.41% | 17/52 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 44.73% | -14.99% | -5.67% | 23/52 | 42.48% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 47.42% | -9.66% | -4.23% | 18/52 | 43.07% | *ST生物 | 84.53% | 行业排名> |
| 2021-06-30 | 49.52% | -7.45% | 1.44% | 13/52 | 42.6% | *ST生物 | 83.19% | 行业排名> |
| 2021-03-31 | 48.81% | -11.94% | -7.25% | 7/52 | 39.47% | *ST生物 | 83.9% | 行业排名> |
| 2020-12-31 | 52.63% | -13.91% | 0.25% | 12/52 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 52.49% | -11.22% | -1.89% | 4/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 53.5% | -12.51% | -3.48% | 9/52 | 39.28% | *ST生物 | 78.74% | 行业排名> |
| 2020-03-31 | 55.43% | -1.48% | -9.33% | 5/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 61.13% | 4.96% | 3.39% | 6/52 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 59.13% | 1.46% | -3.31% | 5/52 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 61.15% | 7.94% | 8.7% | 5/52 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 56.26% | 2.68% | -3.4% | 7/52 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 58.24% | -4.73% | -0.07% | 4/52 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 58.28% | -5.81% | 2.86% | 3/52 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 56.66% | -8.12% | 3.4% | 4/52 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 54.79% | -6.86% | -10.37% | 7/52 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 61.13% | -2.62% | -1.2% | 3/52 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 61.87% | -1.94% | 0.34% | 4/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 61.66% | 944.34% | 4.81% | 4/52 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 58.83% | 764.29% | -6.28% | 3/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 62.77% | 1626.07% | -0.51% | 3/52 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 63.09% | 1261.9% | 968.6% | 2/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 5.9% | 0.26% | -13.26% | 23/52 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 6.81% | 114.65% | 87.16% | 17/52 | 28.42% | 盈康生命 | 75.69% | 行业排名> |